Immune Checkpoint Blockade in Gastrointestinal Cancers: The Current Status and Emerging Paradigms

Immunotherapy is a rapidly evolving treatment paradigm that holds promise to provide long-lasting survival benefits for patients with cancer. This promise, however, remains unfulfilled for the majority of patients with gastrointestinal (GI) cancers, as significant limitations in efficacy exist with...

Descripción completa

Detalles Bibliográficos
Autores principales: Miljanic, Mihailo, Capasso, Anna, Triplett, Todd A., Eckhardt, S. Gail, Aung, Kyaw L.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer - Medknow 2020
Materias:
Review Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9208391/
https://www.ncbi.nlm.nih.gov/pubmed/35756177
http://dx.doi.org/10.4103/JIPO.JIPO_1_20

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9208391/
https://www.ncbi.nlm.nih.gov/pubmed/35756177
http://dx.doi.org/10.4103/JIPO.JIPO_1_20

Ejemplares similares